CHROMCHENKOVA, E.P.,
BOKOV, D.O.,
BESSONOV, V.V.,
SAMYLINA, I.A.,
KAKHRAMANOVA, S.D.,
CHEVIDAEV, V.V.,
SOKHIN, D.M.,
BALOBANOVA, N.P.,
EVGRAFOV, A.A.,
KRASNYUK, J.I.,
KUDASHKINA, N.V.,
GALIAKHMETOVA, E.K.,
MARAKHOVA, A.I.,
MOISEEV, D.V. (2020) a significant amount of arginine, studies involving the prevention and adjunctive
treatment of viral
Zhang, Lu,
Wang, Yi-ning,
Ju, Jia-ming,
Shabanova, Azaliia,
Li, Yue,
Fang, Ruo-nan,
Sun, Jia-bin,
Guo, Ying-ying,
Jin, Tong-zhu,
Liu, Yan-yan,
Li, Tian-yu,
Shan, Hong-li,
Liang, Hai-hai,
Yang, Bao-feng (2020) cardiomyocytes (NMVCs) by H2O2
treatment in vitro. We showed that Mzb1 expression was markedly reduced
LV, L.,
ZHANG, L.,
LI, R.,
LI, Y.,
YANG, R.,
LI, C.,
FANG, R.,
SHABANOVA, A.,
LI, X.,
LIU, Y.,
LIANG, H.,
ZHOU, Y.,
SHAN, H.,
ZHENG, N. (2020) for the
treatment of cardiac conduction delay and provides a new idea of treating arrhythmia with a drug.
НЕВРОЛОГИЧЕСКИЕ И ПСИХИЧЕСКИЕ РАССТРОЙСТВА, АССОЦИИРОВАННЫЕ С COVID-19НОВИКОВА, Л.Б.,
АКОПЯН, А.П.,
ШАРАПОВА, К.М.,
ЛАТЫПОВА, Р.Ф.,
NOVIKOVA L.B.,
AKOPIAN A.P.,
SHARAPOVA K.M.,
LATYPOVA R.F. (2020) -19 epidemic for clinical routine use, further development of the optimal
treatment strategy